Analysts Set Stericycle, Inc. (NASDAQ:SRCL) PT at $74.00

Stericycle, Inc. (NASDAQ:SRCL - Get Free Report) has earned an average recommendation of "Hold" from the six brokerages that are covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and two have issued a buy recommendation on the company. The average 1 year target price among brokers that have covered the stock in the last year is $74.00.

A number of research analysts have recently issued reports on the company. Keefe, Bruyette & Woods boosted their target price on Stericycle from $135.00 to $142.00 and gave the company an "outperform" rating in a report on Tuesday, June 4th. Truist Financial boosted their target price on Stericycle from $50.00 to $62.00 and gave the company a "hold" rating in a report on Tuesday, June 4th. Royal Bank of Canada reissued a "sector perform" rating and issued a $62.00 target price (down previously from $69.00) on shares of Stericycle in a report on Tuesday, June 4th. Finally, StockNews.com assumed coverage on Stericycle in a report on Saturday, August 24th. They issued a "hold" rating on the stock.

Stericycle Stock Performance

SRCL traded up $0.10 during trading on Thursday, hitting $59.01. 2,084,068 shares of the stock were exchanged, compared to its average volume of 1,001,727. The firm has a market capitalization of $5.48 billion, a P/E ratio of -268.14, a PEG ratio of 3.21 and a beta of 1.11. Stericycle has a 1-year low of $37.78 and a 1-year high of $59.45. The stock has a fifty day moving average price of $58.40 and a two-hundred day moving average price of $53.68. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 0.55.

Stericycle (NASDAQ:SRCL - Get Free Report) last released its quarterly earnings results on Thursday, July 25th. The business services provider reported $0.61 EPS for the quarter, topping the consensus estimate of $0.57 by $0.04. The company had revenue of $661.60 million for the quarter, compared to analyst estimates of $672.07 million. Stericycle had a return on equity of 7.94% and a net margin of 1.37%. As a group, sell-side analysts predict that Stericycle will post 2.29 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. Clearstead Trust LLC acquired a new position in Stericycle during the first quarter worth $25,000. Principal Securities Inc. acquired a new position in Stericycle during the fourth quarter worth $41,000. GAMMA Investing LLC grew its holdings in Stericycle by 170.9% during the first quarter. GAMMA Investing LLC now owns 818 shares of the business services provider's stock worth $43,000 after acquiring an additional 516 shares during the period. TFO Wealth Partners LLC boosted its position in Stericycle by 22,325.0% during the fourth quarter. TFO Wealth Partners LLC now owns 897 shares of the business services provider's stock worth $44,000 after purchasing an additional 893 shares in the last quarter. Finally, Headlands Technologies LLC acquired a new stake in Stericycle in the first quarter valued at $44,000. Institutional investors and hedge funds own 98.82% of the company's stock.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.